Among individuals with schizophrenia, the risk for natural-cause mortality was increased in those with reduced cognitive functioning.
New research highlights neuroglia (or glia cells) as critical players in mental health, potentially influencing conditions like depression and schizophrenia.
Shares of AbbVie were getting hammered Monday after the drug maker said two Phase 2 trials of its experimental schizophrenia ...
Researchers are using a groundbreaking technique to visualize a crucial molecule involved in neurotransmission in patients ...
Even though psychiatric disorders such as schizophrenia, bipolar disorder, and autism spectrum disorder (ASD) are quite ...
(Reuters) -Intra-Cellular Therapies said on Tuesday its drug to prevent relapses in schizophrenia patients met the main goal of a late-stage trial. Schizophrenia relapse is the return of symptoms ...
Schizophrenia significantly shortens life expectancy by an estimated 15 years with excess mortality arising from multiple ...
Death risk was twice as high in people with depression, 3-fold higher among those with bipolar disorder, and 4.5 times higher risk among those with schizophrenia, the researchers said. Ill mental ...
Symptoms of schizophrenia, a serious mental disorder that can include hallucinations and delusions, vary greatly from person to person. One common group of schizophrenia symptoms that doesn’t ...
The date of an initial schizophrenia diagnosis was designated ... influencing self-harm and suicide rates were studied, and the causes of death were not able to be validated with other sources ...
A new study conducted on roundworms finds that a common plastic ingredient causes breaks in DNA strands, resulting in egg cells with the wrong number of chromosomes. Monica Colaiácovo of Harvard ...
Appreciating Cobenfy’s novelty and the difference it can make requires awareness of the various effects of schizophrenia, its diagnosis, and scientists’ understanding of what causes it.